Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | ANPEP | P15144 | 1/20 | 0.45 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL3507683 | 0.97 | USP2 (0.56) | USP2ALDH1A1ANPEPPIK3CDLMNA | |
| Hydrochloric Acid SCHEMBL30622074 | 0.97 | ALDH1A1 (0.59) | USP2ALDH1A1ANPEPPIK3CDLMNA | |
| SCHEMBL10232873 | 0.91 | USP2 (0.50) | USP2ALDH1A1ANPEPPIK3CDLMNA | |
| SCHEMBL27296524 | 0.89 | USP2 (0.48) | USP2ALDH1A1ANPEPPIK3CDLMNA | |
| SCHEMBL13066093 | 0.84 | USP2 (0.58) | USP2ALDH1A1ANPEPLMNAMEN1 | |
| SCHEMBL17828102 | 0.84 | USP2 (0.58) | USP2ALDH1A1ANPEPLMNAMEN1 | |
| SCHEMBL20886095 | 0.82 | USP2 (0.42) | USP2ALDH1A1ANPEPPIK3CDMEN1 | |
| SCHEMBL26270866 | 0.81 | HSD17B10 (0.67) | USP2ALDH1A1ANPEPPIK3CDLMNA | |
| SCHEMBL24688084 | 0.80 | USP2 (0.67) | USP2ALDH1A1ANPEPLMNAMEN1 | |
| SCHEMBL14498526 | 0.80 | USP2 (0.54) | USP2ALDH1A1ANPEPLMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1352 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260118765-A1 | RESIST UNDERLAYER FILM FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2026-04-30 | — | — | US | claimed |
| US-12509598-B2 | Process solution composition for polymer treatment comprising a fluorine compound, a ketone solvent, and a polar aprotic solvent | DONGWOO FINE-CHEM CO., LTD. (KR) | 2025-12-30 | — | — | US | claimed |
| CN-116178672-B | Sulfamic acid modified polyisocyanate and preparation method and application thereof | 万华化学集团股份有限公司 | 2025-05-13 | — | — | CN | claimed |
| US-20250075147-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS | OSMO LABS, PBC | 2025-03-06 | — | — | US | claimed |
| US-20250004367-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2025-01-02 | — | — | US | claimed |
| CN-118974659-A | Composition for forming resist underlayer film | 日产化学株式会社 | 2024-11-15 | — | — | CN | claimed |
| CN-117980823-A | Composition for forming resist underlayer film | 日产化学株式会社 | 2024-05-03 | — | — | CN | claimed |
| EP-3724251-B2 | IONICALLY HYDROPHILIZED POLYISOCYANATES, WATER CONTENT | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2023-11-22 | — | — | EP | claimed |
| WO-2023189803-A1 | RESIST UNDERLAYER FILM FORMING COMPOSITION | 日産化学株式会社 | 2023-10-05 | — | — | WO | claimed |
| EP-3851472-B1 | IONICALLY HYDROPHILIZED POLYISOCYANATES, WATER CONTENT | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2023-06-07 | — | — | EP | claimed |
| US-5831093-A | CATALYTIC HYDROGENATION OF NITRO COMPOUNDS | BASF AKTIENGESESCHAFT (DE) | 1998-11-03 | — | — | US | claimed |
| CN-1169715-A | Process for producing N-arylhydroxylamines and N-hetarylhydroxylamines | BASF AG (DE) | 1998-01-07 | — | — | CN | claimed |
| EP-0805797-A1 | PROCESS FOR PRODUCING N-ARYLHYDROXYLAMINES AND N-HETARYLHYDROXYLAMINES | BASF AKTIENGESELLSCHAFT (DE) | 1997-11-12 | — | — | EP | claimed |
| WO-1996022967-A1 | PROCESS FOR PRODUCING N-ARYLHYDROXYLAMINES AND N-HETARYLHYDROXYLAMINES | BASF AKTIENGESELLSCHAFT (DE) | 1996-08-01 | — | — | WO | claimed |
| EP-0138669-B1 | PROCESS FOR THE PREPARATION OF SILANES FROM METHYLDICHLOROSILANE AND CHLOROSILANES | RHONE-POULENC CHIMIE (FR) | 1988-08-10 | — | — | EP | claimed |
| EP-0138670-B1 | PROCESS FOR THE PREPARATION OF SILANES WITH A SI-H BOND BY REDISTRIBUTION | RHONE-POULENC CHIMIE (FR) | 1988-05-25 | — | — | EP | claimed |
| US-4746752-A | QUATERNARY OR TERTIARY AMINE CATALYST | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1988-05-24 | — | — | US | claimed |
| US-4605543-A | DISTRIBUTION AND DISPROPORTIONATION CATALYSIS | RHONE-POULENC SPECIALITIES CHIMIQUES (FR) | 1986-08-12 | — | — | US | claimed |
| EP-0138669-A2 | Process for the preparation of silanes from methyldichlorosilane and chlorosilanes | RHONE-POULENC CHIMIE (FR) | 1985-04-24 | — | — | EP | claimed |
| EP-0138670-A2 | Process for the preparation of silanes with a Si-H bond by redistribution | RHONE-POULENC CHIMIE (FR) | 1985-04-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260118765-A1 | RESIST UNDERLAYER FILM FORMING COMPOSITION | ASH2L, ASIC1, RPA1 | USP2 3578/4885ALDH1A1 1704/4885ANPEP 4834/4885 |
| US-12509598-B2 | Process solution composition for polymer treatment comprising a fluorine compound, a ketone solvent, and a polar aprotic solvent | CHRM1, CHRM2, PNMT | USP2 4112/4885ALDH1A1 1453/4885ANPEP 1237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.